# ABSTRAL
> **NDA022510** · New Drug Application · Sponsor: SENTYNL THERAPS INC · Approved 2011-01-07
## Drug
- **FDA Application Number:** NDA022510
- **Application type:** New Drug Application
- **Brand name:** ABSTRAL
- **Generic name:** Fentanyl Citrate
- **Active ingredients:** FENTANYL CITRATE
- **Dosage form:** TABLET
- **Route:** SUBLINGUAL
- **Marketing status:** Discontinued
- **Sponsor:** SENTYNL THERAPS INC
- **First approval:** 2011-01-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022510)
---
*AI Analytics · CC0 1.0*